Flower One Announces Filing Date and Details for First Quarter 2020 Earnings Call and Releases Preliminary Second Quarter 2020 Revenue Results

 Q2 2020 Preliminary Unaudited Revenue of US$3.8M Beats Company Guidance  -Flower One Holdings Inc. (the “Company” or “Flower One”) (CSE: FONE) (OTCQX: FLOOF) (FSE: F11), a leading cannabis cultivator, producer and innovator in Nevada, today announced that it expects to file its Q1 2020 financial statements after market close on Wednesday, July 15, 2020. Flower One will also host aContinue reading “Flower One Announces Filing Date and Details for First Quarter 2020 Earnings Call and Releases Preliminary Second Quarter 2020 Revenue Results”

WILDFLOWER REPORTS REVENUES OF $5.3 MILLION

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — via NetworkWire – Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) announces $5.3M in revenues in its third quarter, compared to $2.5M in the previous year’s third quarter and $5.5M in the second quarter. Revenues were slightly less than last quarter even though business was affected byContinue reading “WILDFLOWER REPORTS REVENUES OF $5.3 MILLION”

Organigram announces first phase of return-to-work strategy

Company recalls approximately 50 employees to core roles across organization MONCTON, New Brunswick–(BUSINESS WIRE)–As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has announced the first phase ofContinue reading “Organigram announces first phase of return-to-work strategy”

Hollister Biosciences Inc. CEO Provides Corporate Update

VANCOUVER, May 13, 2020 /CNW/ – Hollister Biosciences Inc. (CSE: HOLL, OTC: HSTRF,  FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to provide a Corporate Update from CEO, Carl Saling. “As the country begins to emerge from stay at home orders, we thought it would be prudent toContinue reading “Hollister Biosciences Inc. CEO Provides Corporate Update”